Blair William & CO Volitionrx LTD Transaction History
Blair William & CO
- $34.8 Billion
- Q2 2025
A detailed history of Blair William & CO transactions in Volitionrx LTD stock. As of the latest transaction made, Blair William & CO holds 40,000 shares of VNRX stock, worth $25,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$25,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VNRX
# of Institutions
27Shares Held
22.3MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY10.2MShares$6.42 Million3.7% of portfolio
-
Armistice Capital, LLC New York, NY8.21MShares$5.17 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA765KShares$481,8810.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$325,1250.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $36.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...